Hikal, Pfizer Sign Agreement for API Supply
ePT--the Electronic Newsletter of Pharmaceutical Technology
Pfizer and Hikal signed a contract manufacturing agreement in which Hikal will supply active pharmaceutical ingredients.
Mumbai, India (Jan. 7)-Pfizer (New York) and Hikal signed a contract manufacturing agreement in which Hikal will supply active pharmaceutical ingredients. Terms of the agreement were not disclosed at press time.
“We are extremely pleased to be selected as a long-term contract manufacturer by Pfizer,” said Jai Hiremath, vice chairman and managing director of Hikal in a company statement. “This agreement will have a substantial impact on our pharmaceutical business in the coming years.”
“We look forward to working with Hikal, a respected contract manufacturing company and are delighted that they are able to contribute towards supply of APIs for Pfizer products,” said Peter Stevenson, vice-president, global contract manufacturing, procurement and Pfizer Center Source, Pfizer Inc., in a prepared statement.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
